Survey ranking of emetogenic control in children receiving chemotherapy

American Journal of Pediatric Hematology/Oncology

Volumn 22, Issue 2, 2000, Pages 125-132

  Small, Barbara E ^a   Holdsworth, Mark T ^b   Raisch, Dennis W ^c   Winter, Stuart S ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c University of New Mexico   (United States)

Author keywords

Antiemetics; Chemotherapy side effects; Childhood cancer; Children; Emesis; Nausea and vomiting

Indexed keywords

CARBOPLATIN; CISPLATIN DERIVATIVE; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHYLPREDNISOLONE; ONDANSETRON; PROCARBAZINE; SEROTONIN ANTAGONIST; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CHILD; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; VOMITING;

AGE FACTORS; ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APPETITE; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DACTINOMYCIN; EMETICS; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; NAUSEA; SEX CHARACTERISTICS; TREATMENT OUTCOME; VINCRISTINE; VOMITING;

EID: 0034457401     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200003000-00009     Document Type: Article

References (20)

1. Roila F. Ondansetron plus dexamethasone compared to the ‘standard’ metoclopramide regimen. Oncology 1993;50: 163-7.
2. Italian Group for Antiemetic Research. Ondansetron + dexamethasone vs. metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Lancet 1992;340: 96-9.
3. Hählen K, Quintana E, Pinkerton R, et al. A randomized comparison of intravenously administered granisetron versus chlorpromazine plus dexamethasone in the prevention of ifosfamide-induced emesis in children. J Pediatr 1995;126: 309-13.
4. Dick GS, Meller ST, Pinkerton CR. Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis. Arch Dis Child 1995;73: 243-5.
5. Billett AL, Sallan SE. Antiemetics in children receiving cancer chemotherapy. Support Care Cancer 1994;2: 279-85.
6. Foot ABM, Hayes C. Audit of guidelines for effective control of chemotherapy and radiation induced emesis. Arch Dis Child 1994;71: 475-80.
7. Gandara DR, Roila F, Warr D, et al. Consensus proposal for 5HT(3) antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy: Dose, schedule and route of administration. Support Care Cancer 1998;6: 237-43.
8. 3 antagonist ondansetron: An effective outpatient antiemetic in cancer treatment. Arch Dis Child 1990;65: 822-5.
9. Relling MV, Mulhern RK, Fairclough D, et al. Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy. J Pediatr 1993;123: 811-6.
10. Holdsworth MT, Raisch DW, Duncan MH, et al. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia. Ann Pharmacother 1995;29: 16-21.
11. Holdsworth MT, Raisch DW, Winter SS, et al. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron. Support Care Cancer 1998;6: 132-8.
12. Alvarez O, Freeman A, Bedros A, et al. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies. J Pediatr Hematol Oncol 1995;17: 145-50.
13. Holdsworth MT, Chavez C. Development of a Home Chemotherapy Program for Pediatric Oncology Patients. J Pharm Prac 1995;6: 297-302.
14. Lindley CM, Bernard S, Fields SM. Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population. J Clin Oncol 1989;7: 1142-9.
15. Roila F, Tonato M, Cognetti F, et al. Prevention of cisplatin-induced emesis: A double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991;9: 675-8.
16. LeBaron S, Zeltzer LK, LeBaron C, et al. Chemotherapy side effects in pediatric oncology patients: Drugs, age and sex as risk factors. Med Pediatr Oncol 1998;6: 263-8.
17. Tyc VL, Mulhern RK, Fairclough D, et al. Chemotherapy induced nausea and emesis in pediatric cancer patients: External validity of child and parent emesis ratings. J Dev Behav Pediatr 1993;4: 236-41.
18. Zeltzer LK, LeBaron S, Zeltzer PM. A prospective assessment of chemotherapy-related nausea and vomiting in children with cancer. Am J Pediatr Hematol Oncol 1984;6: 5-16.
19. Hesketh PJ, Kris MG, Grunberg SM, et al. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 1997;15: 103-9.
20. Osoba D, Zee B, Pater J, et al. Determinants of postchemotherapy nausea and vomiting in patients with cancer. J Clin Oncol 1997;15: 116-23.